NCT07459647Phase 2Recruiting

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Study sponsor: MapLight Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-02Estimated
Enrollment · participants500Estimated
Source updated2026-10-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source